BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
36.67
-2.18 (-5.61%)
At close: Aug 21, 2026
-66.66% (1Y)
| Market Cap | 15.96B -65.5% |
| Revenue (ttm) | 1.30B +9.1% |
| Net Income | 50.85M -63.2% |
| EPS | 0.12 -63.7% |
| Shares Out | 435.23M |
| PE Ratio | 313.87 |
| Forward PE | n/a |
| Dividend | 0.02 (0.04%) |
| Ex-Dividend Date | Jun 9, 2026 |
| Volume | 15,655,280 |
| Open | 37.80 |
| Previous Close | 38.85 |
| Day's Range | 36.05 - 37.98 |
| 52-Week Range | 28.74 - 113.00 |
| Beta | 0.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 31, 2026 |